Fluorescent cystoscopy-assisted en bloc transurethral resection versus conventional transurethral resection in patients with non-muscle invasive bladder cancer: study protocol of a prospective, open-label, randomized control trial (the FLEBER study)

[1] Miyake M(2015)Exploration of risk factors predicting outcomes for primary T1 high-grade bladder cancer and validation of the Spanish Urological Club for Oncological Treatment scoring model: long-term follow-up experience at a single institute Int J Urol 22 541-547

[2] Gotoh D(2010)Photodynamic diagnosis in non-muscle-invasive bladder cancer:a systematic review and cumulative analysis of prospective studies Eur Urol 57 595-606

[3] Shimada K(2013)Photodynamic diagnosis of non-muscle-invasive bladder cancer with hexaminolevulinate cystoscopy:a meta-analysis of detection and recurrence. Based on raw data Eur Urol 64 846-854

[4] Tatsumi Y(2012)Treatment changes and long-term recurrence rates after hexaminolevulinate (HAL) fluorescence cystoscopy: does it really make a difference in patients with non-muscle-invasive bladder cancer (NMIBC)? BJU Int 109 549-556

[5] Nakai Y(2010)Fibroblast growth factor receptor 3 mutation in voided urine is a useful diagnostic marker and significant indicator of tumor recurrence in non-muscle invasive bladder cancer Cancer Sci 101 250-258

[6] Anai S(1997)A new technique for transurethral resection of bladder tumors: rotationaltumor resection using a new arched electrode J Urol 157 2225-2226

[7] Kausch I(2001)Transurethral en bloc resection of bladder tumours J Urol 166 2148-2150

[8] Sommerauer M(2010)Transurethral resection in one piece (TURBO) is an accurate tool for pathological staging of bladder tumor Int J Urol 17 708-714

[9] Montorsi F(2015)En bloc transurethral resection with 2-micron continuous-wave laser for primary non-muscle-invasive bladder cancer: a randomized controlled trial World J Urol 33 989-995

[10] Stenzl A(2012)Does En-bloc transurethral resection of bladder tumor give a better yield in terms of presence of detrusor muscle in the biopsy specimen? Indian J Urol 28 275-279

[1] Miyake M(2015)Exploration of risk factors predicting outcomes for primary T1 high-grade bladder cancer and validation of the Spanish Urological Club for Oncological Treatment scoring model: long-term follow-up experience at a single institute Int J Urol 22 541-547

[2] Gotoh D(2010)Photodynamic diagnosis in non-muscle-invasive bladder cancer:a systematic review and cumulative analysis of prospective studies Eur Urol 57 595-606

[3] Shimada K(2013)Photodynamic diagnosis of non-muscle-invasive bladder cancer with hexaminolevulinate cystoscopy:a meta-analysis of detection and recurrence. Based on raw data Eur Urol 64 846-854

[4] Tatsumi Y(2012)Treatment changes and long-term recurrence rates after hexaminolevulinate (HAL) fluorescence cystoscopy: does it really make a difference in patients with non-muscle-invasive bladder cancer (NMIBC)? BJU Int 109 549-556

[5] Nakai Y(2010)Fibroblast growth factor receptor 3 mutation in voided urine is a useful diagnostic marker and significant indicator of tumor recurrence in non-muscle invasive bladder cancer Cancer Sci 101 250-258

[6] Anai S(1997)A new technique for transurethral resection of bladder tumors: rotationaltumor resection using a new arched electrode J Urol 157 2225-2226

[7] Kausch I(2001)Transurethral en bloc resection of bladder tumours J Urol 166 2148-2150

[8] Sommerauer M(2010)Transurethral resection in one piece (TURBO) is an accurate tool for pathological staging of bladder tumor Int J Urol 17 708-714

[9] Montorsi F(2015)En bloc transurethral resection with 2-micron continuous-wave laser for primary non-muscle-invasive bladder cancer: a randomized controlled trial World J Urol 33 989-995

[10] Stenzl A(2012)Does En-bloc transurethral resection of bladder tumor give a better yield in terms of presence of detrusor muscle in the biopsy specimen? Indian J Urol 28 275-279